EAM
Eventide Asset Management Portfolio holdings
AUM
$5.71B
1-Year Return
51.18%
This Quarter Return
+15.71%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$5.92B
AUM Growth
+$466M
(+8.6%)
Cap. Flow
-$22.9M
Cap. Flow
% of AUM
-0.39%
Top 10 Holdings %
Top 10 Hldgs %
26.27%
Holding
165
New
16
Increased
58
Reduced
30
Closed
23
Top Buys
| 1 |
Zentalis Pharmaceuticals
ZNTL
|
$103M |
| 2 |
Guardant Health
GH
|
$76.4M |
| 3 |
Mirum Pharmaceuticals
MIRM
|
$36.2M |
| 4 |
Toast
TOST
|
$36.2M |
| 5 |
Lithia Motors
LAD
|
$36.1M |
Top Sells
| 1 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$71.9M |
| 2 |
Doximity
DOCS
|
$46M |
| 3 |
Palo Alto Networks
PANW
|
$38M |
| 4 |
Enphase Energy
ENPH
|
$36M |
| 5 |
Roper Technologies
ROP
|
$33.6M |
Sector Composition
| 1 | Healthcare | 43.76% |
| 2 | Technology | 24.19% |
| 3 | Industrials | 13.17% |
| 4 | Consumer Discretionary | 7.97% |
| 5 | Utilities | 3.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
EastGroup Properties
EGP
$8.97B
| $5.77M | 0.1% |
33,255
| – | – |
|
127
Transmedics
TMDX
$3.55B
| $5.67M | 0.1% |
+67,461
| New | +$5.67M |
|
128
Arcus Biosciences
RCUS
$1.23B
| $4.87M | 0.08% |
240,000
| – | – |
|
129
Ionis Pharmaceuticals
IONS
$9.46B
| $4.51M | 0.08% |
110,000
| – | – |
|
130
Arteris
AIP
$377M
| $2.72M | 0.05% |
398,774
-124,031
| -24% | -$846K |
|
131
NerdWallet
NRDS
$782M
| $1.41M | 0.02% |
+150,000
| New | +$1.41M |
|
132
NVIDIA
NVDA
$4.18T
| $520K | 0.01% |
12,290
+8,660
| +239% | +$366K |
|
133
ServiceNow
NOW
$186B
| $509K | 0.01% |
906
+188
| +26% | +$106K |
|
134
Edwards Lifesciences
EW
$47.5B
| $482K | 0.01% |
5,108
+1,078
| +27% | +$102K |
|
135
Compass
COMP
$4.92B
| $451K | 0.01% |
+128,879
| New | +$451K |
|
136
Align Technology
ALGN
$9.76B
| $417K | 0.01% |
+1,178
| New | +$417K |
|
137
TSMC
TSM
$1.22T
| $367K | 0.01% |
3,640
+1,613
| +80% | +$163K |
|
138
NextEra Energy, Inc.
NEE
$146B
| $235K | ﹤0.01% |
3,163
-431
| -12% | -$32K |
|
139
ADC Therapeutics
ADCT
$382M
| – | – |
-1,675,959
| Closed | -$3.27M |
|
140
ALX Oncology
ALXO
$57.8M
| – | – |
-664,829
| Closed | -$3.01M |
|
141
Annexon
ANNX
$236M
| – | – |
-1,867,250
| Closed | -$7.19M |
|
142
BILL Holdings
BILL
$4.75B
| – | – |
-264,398
| Closed | -$21.5M |
|
143
Crown Castle
CCI
$41.6B
| – | – |
-235,052
| Closed | -$31.5M |
|
|
144
Enphase Energy
ENPH
$4.78B
| – | – |
-171,081
| Closed | -$36M |
|
145
FibroGen
FGEN
$45.7M
| – | – |
-38,400
| Closed | -$17.9M |
|
146
Generac Holdings
GNRC
$10.5B
| – | – |
-103
| Closed | -$11.1K |
|
147
Immunovant
IMVT
$2.81B
| – | – |
-1,390,000
| Closed | -$21.6M |
|
148
MongoDB
MDB
$26.2B
| – | – |
-81
| Closed | -$18.9K |
|
|
NEE.PRR
149
DELISTED
NextEra Energy, Inc. 6.926% Corporate Units
NEE.PRR
| – | – |
0
| – | -$3.48M |
|
150
PTC Therapeutics
PTCT
$4.61B
| – | – |
-34,047
| Closed | -$1.65M |
|